Insider sale
NUVALENT, INC.
$12.86M
156.67K shares
What this filing means
BCIP LIFE SCIENCES ASSOCIATES, LP plans to sell 156.67K shares of NUVALENT, INC. valued at approximately $12.86M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/24/2025ACC: 0000950170-25-098546
156.67K
Shares to sell
$12.86M
Approx. market value
292.38K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Purchase of preferred stock from the Issuer, which was automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering
Cash
4/30/2021
292.38KTotal acquired292.38K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/30/2021 | Purchase of preferred stock from the Issuer, which was automatically converted into shares of Class A Common Stock immediately prior to the closing of the Issuer's initial public offering Cash | 292.38K | — |
| Total | 292.38K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
156.67K
Market value
$12.86M
7/24/2025
Total
Units
156.67K
Value
$12.86M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/24/2025 | 156.67K | $12.86M | Nasdaq | Planned |
| Total | 156.67K | $12.86M | ||